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Background: Methamphetamine abuse has undergone a dramatic worldwide increase, and represents a significant
and global issue for public health. Incidents of methamphetamine intoxication and death in humans are relatively
commonplace. Because of its increasing illicit availability, together with legitimate use in human medicine,
accidental or intentional exposure to methamphetamine in dogs is becoming a more likely scenario.
Case presentation: A 3-year-old, 3.7 kg intact female Miniature Poodle who had been intentionally fed an
unknown amount of a crystalline-like substance developed extreme agitation, seizures, tachycardia, hyperthermia,
hypertension, disseminated intravascular coagulation (DIC), bloody diarrhea, and dilated pupils. Blood work revealed
leukocytosis, erythropenia, lymphocytosis, thrombocytopenia, coagulation abnormalities, but all to a mild extent,
together with mild elevation in both alanine aminotranferease (ALT) and alkaline phosphatase (ALKP), and a mild
decreased in glucose. Radiologic diagnosis revealed generalized, severe distension of the stomach and small
intestinal tract with air. Immunochromatographic screening tests and gas chromatography mass spectrometry
analysis confirmed methamphetamine intoxication and revealed concentrations of methamphetamine in blood and
urine of 0.32 μg/mL and 2.35 μg/mL respectively. The dog demonstrated progressive improvement after supportive
care, with the high fever resolved over the initial 24 hours of hospitalization, and agitation was successfully
controlled beyond 48 hours after initial hospitalization. Hemostatic abnormalities were progressive improved after
heparin therapy and supportive care. By the sixth day of hospitalization the dog was clinically well, and all
laboratory data had returned to normal with the exception of a mild elevateion of ALKP.
Conclusion: To the authors’ knowledge, this is the second case report of methamphetamine intoxication in dogs
presented in veterinary practice in open literature so far. Although rare, methamphetamine intoxication should be
considered as a differential diagnosis in dogs with a toxic substance ingestion history and with typical nervous and
cardiovascular system symptoms. In such cases rapid diagnosis and aggressive intervention is important for
prognosis. Blood methamphetamine concentration may be a helpful value for assessment of the severity of
intoxication and prediction of clinical outcomes.
Keywords: Methamphetamine, Intoxication, Dog, Agitation, Tachycardia, Hyperthermia, Disseminated intravascular
coagulation, Urine screen test, Gas chromatography mass spectrometryBackground
Methamphetamine, a potent central nervous system (CNS)
stimulant, was first synthesized around 1920 [1] and widely
used in the 1930s for the medical treatment of depression,
obesity, sleep disorders, nasal congestion, and many other
conditions in humans [2-4]. An increasing awareness of* Correspondence: peizengyang@zju.edu.cn
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mine led to the withdrawal of many previously sanctioned
uses of the drug and the addition of the prohibitions relat-
ing to unauthorized possession, use or distribution of the
drug in many countries. Nevertheless, methamphetamine
abuse has been rising over the past decades and has be-
come a serious worldwide health issue. This is considered
to be due to its ease of synthesis, requiring only rudimen-
tary and affordable laboratory equipment and readily avail-
able ingredients for its production, and its resulting highly
addictive properties [5-7]. Currently, methamphetamine isal Ltd. This is an Open Access article distributed under the terms of the Creative
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Figure 1 Skin flush of a dog after unknown amount of
methamphetamine ingestion. The dog progressive presented with
skin flushing and petechiae after ingestion (A), and become normal
after treatment (B).
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its use seems to be increasing [8]. Moreover, medicinal
methamphetamines still remain in limited use for the
treatment of narcolepsy, attention deficit hyperactivity
disorder (ADHD), and obesity [4,9,10]. This escalating
availability and use in humans together with the fact
that there are probably more than 200 million dogs in
China [11], may lead to the increasing likelihood of acci-
dental or intentional methamphetamine exposure in dogs.
It is now well reported in humans and several other
animal models that methamphetamine intoxication is
associated with a number of adverse consequences includ-
ing agitation, aggression, hyperthermia, delirium, cardiac
ischemia, seizures, strokes, rhabdomyolysis, dysfunction of
the liver, heart, kidney, or even death by overdose [12-17].
So far, however, incidences of methamphetamine intoxica-
tion in dogs seem to have had relatively poorly covered,
with only one intoxication case report presented in 1998
[18], two toxicity studies reported in 1965 [19] and 1982
[20], three pharmacokinetic studies conducted from 1995
to 1997 [21-23]. Beyond these there remain very few
case reports relating to primary metabolite amphetamine
intoxication [24-26] published and available in English.
Herein, we report an unusual methamphetamine toxicity
case in a Miniature Poodle dog that had ingested un-
known amounts of methamphetamine.
Case presentation
A 3-year-old, 3.7 kg intact female Miniature Poodle was
taken to the Ai’ xin Small Animal Hospital (Cixi, Zhejiang,
China), with a heart rate of 138, respiratory rate of 62, rec-
tal temperature of 42°C, and intermittent seizures. The
owners initially presented a conflicting and unclear his-
tory. The dog received external cooling without any other
examination or treatment after admission. After continued
conversation with the owners it became clear that the dog
may have been intentionally fed an unknown amount of a
crystalline-like substance by their friends in a nightclub
approximately 1 hour before presentation. They suggested
that ‘ice’, the street name of methamphetamine, may have
been present in the nightclub. The dog had no medical
records in the hospital, but, according to the owner’s de-
scription, had no other remarkable past history. After re-
vealing a possible methamphetamine ingestion history the
owners disappeared, leaving the dog at the hospital.
The dog was taken to the Veterinary Teaching Hospital
of Zhejiang University by a referral veterinarian, and was
provided with continuing external cooling (ice packs). By
this time it was about 2.5 hours beyond ingestion when the
dog was finally presented at the emergency room. The re-
ferral veterinarian reported that the dog was progressively
displaying flushed skin and extensive petechiae in
abdominal region (Figure 1). It also had started to develop
watery bloody diarrhea, and had had 3 short seizures(about 50 seconds for each time seizure) on the way to the
hospital. Physical examination revealed a rectal temperature
of 41.5°C, heart rate of 186 beats per minute with no
premature ventricular contractions or other arrhythmias,
panting respiration, systolic blood pressure of 166 mmHg,
diastolic blood pressure of 117 mmHg, and mean arterial
pressure of 137 mmHg. The dog was alert, responsive and
extremely agitated. It had bilaterally dilated pupils and
displayed rotational locomoter activity (repeatedly circling
in an anticlockwise direction) (Additional file 1: Movie 1).
Blood samples were collected by cephalic venipuncture
and placed in different sets of tubes, with or without anti-
coagulant, for a complete blood count (CBC), a biochem-
ical profile panel and coagulation tests. All these tests were
performed by IDEXX In-house Diagnostics Station (IDEXX
Laboratories, Sacramento, CA). Hematological findings in-
cluded white blood cell count 21,000/μL (reference range
5,050-16,760/μL), red blood cell count 5.1 M/μL (reference
range 5.65-8.87 M/μL), red blood cell specific volume
31.2% (reference range 37.3%-61.7%), platelets 55,000/μL
(reference range 148,000-484,000/μL), lymphocytes 5,300/
μL (reference range 1,050-5,100/μL), and neutrophils
15,000 (reference range 2,950-11,640/μL) with normal seg-
mented neutrophils. The results of the biochemical panel
revealed mildly elevated alanine aminotranferease (ALT;
112 U/L, reference range is 10-100 U/L) and mildly ele-
vated alkaline phosphatase (ALKP; 238 U/L, reference
range is 23-212U/L) concentrations, with mildly decreased
glucose (70 mg/dL, reference range 74-143 mg/dL). The
prothrombin time (PT) was 16.8 seconds (reference range
11.0-14.0 seconds) and the activated partial thromboplastin
time (aPTT) was 125.0 seconds (reference range 60.0-93.0).
Blood gas was also evaluated by electrolyte analysis and
a blood gas analyzer (IDEXX Laboratories, Sacramento,
CA) and the results revealed a pH of 7.20 (reference range
7.31-7.42) and a base deficit of 17.8 mmol/L (HCO3
−, refer-
ence range 20.0-29.0 mmol/L), with unremarkable potas-
sium, chloride and sodium concentrations. An x-ray of the
chest and abdomen appeared normal with exception of
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tract with air. Portions of the colon were also air filled.
Presumptive diagnosis was functional or paralytic ileus
(Figure 2). The urine test was unremarkable without
any pathologic casts.
At the time of presentation at the emergency unit, a
preliminary drug screen on urine was performed using
rapid competitive immunochromatographic screening tests
(ABON Biopharm, Zhejiang, China) for the detection
of ketamine, methamphetamine, methadone, or morphine.
The screening tests showed positive results only for
methamphetamine (Figure 3A). At the same time, the
blood and urine samples were collected and submitted to
Zhejiang Forensic Medical Examination Center (Hangzhou,
Zhejiang, China) for the confirmation and quantification of
the methamphetamine present in blood using gas chroma-
tography mass spectrometry (GC-MS). The GC-MS results
were provided by the police reports. Quantitative test re-
vealed that the methamphetamine concentrations in serum
and urine were 0.32 μg/mL and 2.35 μg/mL, respectively.
After the blood samples were taken, the dog was placed
in a quiet room with minimum external stimulation. In
order to treat the hyperthermia and maintain an adequate
urine output, a venous catheter (Introcan; B. Braun Trading
Corp, Shanghai, China) was placed in one cephalic vein for
fluid administration, using 0.9% Sodium Chloride Solution.
External cooling was continued using ice packs, and the
rectal temperature was continually monitored to prevent
possible hypothermia. The dog was given 3.6 mEq of intra-
venous sodium bicarbonate to correct the base deficit over
the first 12 hours. The dosage then was adjusted according
to the subsequent blood gas analysis. An intermittent in-
travenous injection of 50% Glucose Solution was given as
appropriate based on continuous monitoring of serum glu-
cose for the regulation of mild hypoglycemia. Subcutaneous
amoxicillin and clavulanate potassium (7 mg/kg amoxicillin
and 1.75 mg/kg clavulanate potassium as effective; Synulox
Injection, Pfizer, New York) was begun on admission, and
withdrawn within 4 days after the white blood cell count
returned to normal and after confirming that urine culturesFigure 2 Radiograph of the abdominal region in a dog with
methamphetamine intoxication. A: Right lateral view. B: Ventral
dorsal view. Note generalized, severe distension of the stomach and
small intestinal tract with air. Portions of the colon were also air
filled. Presumptive diagnosis was functional or paralytic ileus.proved no growth of bacteria. Intravenous phenobarbital
(4 mg/kg; Sodium Phenobarbital Injection, Tianjin Pharma.,
Tianjin, China) and acepromazine (0.05 mg/kg; Aceproma-
zine injection, Mavlab Pty Ltd, Queensland, Australia) were
given to control seizures and agitation. The dog was started
on low-molecular-weight heparin to control coagulation
abnormalities, supported with intravenous fluids for main-
taining sufficient microvascular perfusion.
Over the initial 24 hours of hospitalization, the dog dem-
onstrated progressive improvement, with the high fever
resolved (between 36.5 and 37.6°C), normal serum glucose
concentration, and sufficient urine output. After adminis-
tration of phenobarbital and acepromazine the dog was
lay down in the cage and ceased its repetitive circling.
Nevertheless, it still had several short seizures and
displayed occasional muscle twitching. Following the re-
petitive administration of phenobarbital and acepromazine
no more seizures, muscle twitching, or repetitive circ-
ling behaviors were observed (beyond 48 hours after
hospitalization). Urine was screened again on day 3 using
the same rapid assay and at that time failed to reveal
the presence of methamphetamine. By the sixth day of
hospitalization the dog was clinically well (no diarrhea, no
petechiae, no pupillary dilation, and eating and drinking
well) and all laboratory data had returned to normal with
the exception of a mildly elevated ALKP (220 U/L, refer-
ence range 23-212 U/L). The dog was sent to local veterin-
ary hospital with no further medications.
Discussion
As methamphetamine abuse continues to rise due to its
increasing availability, the likelihood of accidental poison-
ing in companion animals increases. Therefore, a better
understanding of methamphetamine intoxication for small
animal veterinary practice is urgently needed. Metham-
phetamine toxicity predominantly affects the nervous and
cardiovascular systems [3,4,12]. Following oral administra-
tion, methamphetamine is well-absorbed into the blood-
stream, metabolized in the liver, and excreted by the
kidney both as methamphetamine in its unchanged form
and as its main metabolite amphetamine. Both metham-
phetamine and amphetamine directly or indirectly trigger
the release of dopamine from neurons in the CNS. This
leads to stereotypical behaviors such as rearing, licking,
and gnawing, and other forms of increased locomotor ac-
tivity in animal models [4,12,27]. Similar to the neurotoxic
effects on the dopamine system, methamphetamine can
also affect glutamatergic, serotonergic and noradrenergic
neurotransmission, which subsequently contributes to sti-
mulation of the sympathetic nervous system with tachy-
cardia, hyperthermia, hypertension, agitation, and dilated
pupils resulting [3,4,12]. In this case, the most prominent
presenting symptoms were agitation, with signs of restless,
short seizures, and rotational locomoter activity (circling).
Figure 3 Rapid competitive immunochromatographic screening tests for the detection of ketamine, methamphetamine, methadone,
or morphine. The screening tests showed positive results only for methamphetamine (A). The interpretation of test (B) is based on the pink
coloured bands appearing at the control region (C) and at the test region (T). Two pink coloured bands appearing at C and T region indicates
absence of methamphetamine in the specimen. Only one pink coloured band appearing at the C region indicates the specimen contains a
detectable amount of methamphetamine. If no band appears at the C region, this indicates the test result is invalid.
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sion, hyperthermia, and tachycardia. All these symptoms
were consistent with previous studies of methampheta-
mine toxicity in dogs [18-23].
Moreover, the skin petechiae of the dog, together with
the mild thrombocytopenia, prolonged PT and aPTT,
were consistent with disseminated intravascular coagula-
tion (DIC). DIC was reported to be found in metham-
phetamine or amphetamine toxicity in both dogs and
humans [3,25,27]. The mechanism of methamphetamine-
mediated DIC is unknown but it is probably associated
with hyperthermia because previous studies have shown
that thrombocytopenia and coagulation abnormalities are
commonly seen in dogs with fever and heat-induced
illnesses [28-30]. Methamphetamine has also been associ-
ated with severe abdominal pain, vomiting, bloody diarrhea,
and gut ischemia in humans, especially when it was taken
orally [7,12]. Recently, unusual cases of methamphetamine-
associated intestinal infarction, paralytic ileus, and ischemic
colitis have been reported in human patients [31-33]. The
mechanism by which methamphetamine can induce gas-
trointestinal disorders has been proposed to be by direct
affects on cocaine-regulation and upon the amphetamine-
regulated transcript peptide as well as indirect effects
from the release of dopamine and other neurotransmit-
ters [34,35]. Similarly, our case presented with frequent
bloody diarrhea and severe distension of the stomach
and small intestinal tract with air during the first 2 days
of hospitalization. Portions of the colon were also air
filled. Further examinations such as computed tomog-
raphy scan, mesenteric angiography, colonoscopy, or tis-
sue biopsy may be options for diagnosis of acute intestinal
ischemia, intestinal infarction and paralytic ileus. In this
case, we did not perform these further examinations be-
cause of the low budget and also because the dog im-
proved quickly with supportive care. Although we werenot able to identify the definitive pathogeny of the gastro-
intestinal disorder in this dog, the presumptive diagnosis
of functional or paralytic ileus can be made given the pre-
vious reports [31-33].
The diagnosis of methamphetamine toxicosis should be
based primarily on the recognition of the clinical symp-
toms of extremely agitation, seizures, tremors, persistent
tachycardia, hypertension, hyperthermia, and other sym-
pathominetic effects [3,18,24,26]. Other drugs such as
cocaine, ephedrine, pseudoephedrine, methylxanthines, or
strychnine can cause similar CNS stimulation must be
included in a differential diagnosis list for methampheta-
mine toxicosis. Details of ingestion history within 0.5-3
hours before the first episode of symptom can be very
helpful for diagnosis, as ingestion is the primary route for
methamphetamine administration in companion animals.
Ingested methamphetamine may take about 20 minutes to
induce symptoms with the peak plasma methampheta-
mine concentrations achieved at approximately 2-3 hours
post ingestion [27,36]. Other supporting laboratory tests
such as CBC, blood gas, electrolytes, electrocardiogram,
serum glucose, biochemical panel, and coagulation status
should be performed as clinically indicated.
When taken orally, 30-54% of the dose is excreted in
urine as methamphetamine and 10-23% as amphet-
amine [36]. Therefore, urine qualitative testing for me-
thamphetamine or its metabolite amphetamine may
confirm methamphetamine intoxication and possibly
exclude other common illicit drugs as factors. The drug
screening kits used in this case are rapid, qualitative,
immunochromatographic assays for the detection of the
presence of illicit drugs in urine specimens, at concen-
trations as low as 1000 ng/mL for methamphetamine
and ketamine, or 300 ng/mL for methadone and mor-
phine. These kits are based on the principle of agglutin-
ating sera on membrane and utilize the technique of
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scribed [37]. The test procedure takes around 10 minutes
and was performed in several simple steps. A negative
result produces two pink coloured bands, one at the
control region (C) and the other at the test region
(T). In contrast, the absence of this pink coloured
band in the T region indicates the specimen contains
a detectable amount of methamphetamine. For the test
to be valid, the C region must show a pink coloured
band (Figure 3B).
Although the validations of these urine screening tests
for use in companion animals have not been confirmed,
this may be because the incidences of illicit drug toxicosis
in companion animals are relatively rare and it may be
considered not worth the effort to confirm the validation.
However, one study in 2009 confirmed that the screening
test kit did successfully identify methamphetamine/am-
phetamine, barbiturates, opiates, and benzodiazepines in
urine from dogs that had received these common illicit
drugs either intravenously and/or orally [38]. In our case,
the screening tests showed positive results only for meth-
amphetamine consistent with the ingestion history and
clinical symptoms. Moreover, the blood and urine samples
of the dog were collected and submitted for quantitative
GC-MS analysis, which allowed positive structural iden-
tification and quantitation of the analyte that produced
the positive result in the screening tests. The concentra-
tion of methamphetamine was 0.32 μg/mL in blood,
and 2.35 μg/mL in urine. The results of screening tests
and GC-MS analysis were strongly suggested metham-
phetamine poisoning in the present case.
There is no specific antidote for methamphetamine
intoxication and treatment is generally supportive care
[3,18,24,26]. Gastrointestinal decontamination with acti-
vated charcoal is an early therapeutic option if the animal
is seen within 30 minutes of ingestion. Blood pressure, res-
piration, heart rate and rhythm must all be strictly moni-
tored and treated as appropriate. Hyperthermia must be
diagnosed rapidly and treated aggressively using intraven-
ous fluids, fans, ice packs, or cool-water baths, as severe
persistent hyperthermia is associated with poor clinical
outcome [24,27]. Agitation or seizures should be treated
initially with benzodiazepines, or phenobarbital and/or
propofol if seizure activity persists. Acepromazine has also
been recommended in such cases with dosage titrated to
achieve adequate sedation [24]. Extreme agitation and
frequent episodes of seizures have also been associated
with poor outcomes, even suddenly death, post ingestion
[15,18,27]. If the animal presented with myoglobinuria
and other signs of rhabdomyolysis, aggressive crystalloid
fluid must be used appropriately to maintain renal func-
tion, assure adequate urinary output, and promote the
elimination of methamphetamine and its metabolites.
Gastrointestinal decontamination was not applied in thiscase because it had been about 2.5 hours post ingestion
before the dog had been presented at our emergency
room, and the dog presented prominent clinical signs. The
dog demonstrated progressive improvement after support-
ive care, with the high fever resolved over the initial
24 hours of hospitalization, and agitation successfully con-
trolled beyond 48 hours of hospitalization. By the sixth
day of hospitalization the dog was clinically well, and all
laboratory data had returned to normal with the exception
of mildly elevated of ALKP.
The prognosis of methamphetamine intoxication gener-
ally depends on the severity of poisoning. Toxic doses of
methamphetamine vary widely in different species, with
the median lethal dose (LD50) reported as 70 mg/kg (via
intra-peritoneal injection) for rats, 43 mg/kg (intra-peri-
toneal injection) for mice. 140-1650 mg (oral or intraven-
ous injection) is considered potentially lethal for humans
[39]. According to a previous study, the oral LD50 for
methamphetamine hydrochloride in dogs can be range
anywhere from 9 to 11 mg/kg [19]. The concentration of
methamphetamine in the blood is often determined to as-
sess the severity of methamphetamine poisoning. There
are several human medical studies which provide a three-
fold classification of methamphetamine concentration in
the blood into fatal, toxic and therapeutic concentrations
[40,41]. Although the results of those studies were not
perfectly matched, the therapeutic methamphetamine
blood concentrations were estimated to range from 0.01
to 0.05 μg/mL, the toxic concentrations from 0.6 to
5.0 μg/mL, and the lethal concentrations as above 10 μg/
mL. In this case, the methamphetamine concentration in
blood reached 0.32 μg/mL, which exceeds the therapeutic
concentration of this classification despite the dog recov-
ery uneventfully. This suggested that the therapeutic blood
concentrations for methamphetamine in humans and dogs
may differ, although no studies have been done yet to test
either therapeutic or toxic methamphetamine blood con-
centrations in dogs.
Conclusion
In conclusion, our case report describes a dog that had
ingested an unknown amount of methamphetamine. This
led to a syndrome characterized by extremely agitation,
seizures, tachycardia, hyperthermia, hypertension, DIC,
bloody diarrhea, and dilated pupils. Urine screening tests
and GC-MS analysis confirmed methamphetamine intoxi-
cation in this dog, with the concentrations of metham-
phetamine in blood and urine of 0.32 μg/mL and 2.35 μg/
mL respectively. To the authors’ knowledge, this is the
second case report of methamphetamine intoxication in
dogs presented in a veterinary practice context in open
English literature so far. Although rare, methamphetamine
intoxication should be considered as a differential diagno-
sis in dogs which have toxic substance ingestion history
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systems symptoms. Here, rapid diagnosis and aggressive
intervention is important for prognosis. Blood metham-
phetamine concentrations may be helpful for assessment
of the severity of intoxication and the prediction of clinical
outcomes. Further studies need to be done to classify the
blood methamphetamine concentration ranges for fatal,
toxic and therapeutic concentrations in dogs.
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